Schlusskurs
Andere Börsenplätze
|
||
- | - |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Ron Philip
CEO | Chief Executive Officer | - | 01.05.17 |
Gallia Levy
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 50 | 25.09.17 | |
Blake Sprayberry
PRN | Corporate Officer/Principal | - | - |
Chris Stevens
PRN | Corporate Officer/Principal | - | 01.01.22 |
Corporate Officer/Principal | - | 01.01.17 | |
Corporate Officer/Principal | - | 16.11.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Sean Johnston
BRD | Director/Board Member | - | 17.12.19 |
Bruce Resnick
BRD | Director/Board Member | - | 17.12.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 38 944 971 | 36 835 813 ( 94,58 %) | 421 677 ( 1,083 %) | 94,58 % |
Unternehmenskontakt
Spark Therapeutics, Inc.
3737 Market Street Suite 1300
19104, Philadelphia
+215 220 9300
http://www.sparktx.comSektor
% 1. Jan. | Kap. | |
---|---|---|
-2.31% | 103 Mrd. | |
+0.56% | 95.28 Mrd. | |
+1.69% | 22.15 Mrd. | |
-17.37% | 21.02 Mrd. | |
-9.30% | 18.15 Mrd. | |
-41.01% | 16.73 Mrd. | |
-14.85% | 16.05 Mrd. | |
+3.21% | 13.68 Mrd. | |
+33.54% | 12.17 Mrd. |